Health Discovery Inks Agreement with Patent Profit International

SAVANNAH, GA - Health Discovery Corporation announced in a Tuesday press release the signing of an Agreement with Patent Profit International (PPI), a Silicon Valley-based patent brokerage firm, with the goal of exploiting the full monetization potential of HDC's extensive pioneering patent portfolio.

Under the agreement, PPI will market HDC's patent portfolio, which includes exclusive rights to SVM techniques and applications that reach far beyond biomarker discovery and the Healthcare Field, to prospective buyers/licensees in a wide range of technologies, including, but not limited to, information technology such as Internet browsers and search engines, spam mail detection, oil exploration, homeland security, and the automotive industry.

As a requirement of any sale of the patent estate, HDC expects to retain a royalty-free, worldwide, exclusive license, with the right to grant sublicenses, in the entire field of healthcare.

This strategic initiative would allow HDC to potentially generate significant revenue from its extensive and pioneering patent estate covering the field of SVM technology in non-medical applications.

This is a strategy designed to transform HDC's underutilized patents into working financial assets to increase shareholder value.

The advances covered by the patents in the HDC portfolio represent work by several of the world's leading authorities in the field of SVMs and learning machines including Dr. Isabelle Guyon, one of the original SVM inventors at Bell Labs and a member of HDC's Scientific Advisory Board.

A few of the other HDC inventors include Dr. Bernhard Schoelkopf, also a member of HDC's Science Advisory Board and currently a department director at the Max Planck Institute for Biological Cybernetics in Tübingen, Germany and co-author or co-editor of numerous books and published articles on pattern recognition and learning machines.

Dr. Nello Cristianini is a professor of artificial intelligence at the University of Bristol and co-author of two well-known books on machine learning.

The sale of HDC's patent portfolio to a high tech company with extensive resources for establishing an aggressive licensing and enforcement program is a wining solution that could generate significant working capital for realizing HDC's primary mission.

Savannah-based Health Discovery Corporation is uniquely positioned in the field of pattern recognition technology.